Literature DB >> 3758817

Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption.

Z Weizman, P R Durie, H R Kopelman, S M Vesely, G G Forstner.   

Abstract

In order to define basic biliary defects not related to steatorrhoea in cystic fibrosis, we studied 12 control and 18 cystic fibrosis subjects, with a wide range of pancreatic function. Duodenal aspirates were collected over three consecutive 20 minute periods, during continuous intravenous infusion of cholecystokinin and secretin using a marker perfusion technique, and analysed for pancreatic enzyme output (colipase, lipase, trypsin), bile acid output and concentration, and biliary lipids. Cystic fibrosis patients, at all levels of pancreatic function, had significantly reduced total bile acid output (mumol/kg/h) with delayed appearance of the bile acid peak, compared with control subjects. Actual duodenal bile acid concentrations were significantly higher in cystic fibrosis subjects than in controls, however, probably because of the markedly reduced water output shown in these patients. The lithogenic index was not raised in cystic fibrosis patients at any level of pancreatic function. The reduced bile acid output and the delayed peak appearance probably reflect a defect in gall bladder responsiveness which is independent of pancreatic function and steatorrhoea. Whether this defect is related to gall bladder filling or a defective peptide hormone response awaits further study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758817      PMCID: PMC1433794          DOI: 10.1136/gut.27.9.1043

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  [Anomalies of the gallbladder in mucoviscidosis. Apropos of 57 cases].

Authors:  J Feigelson; J L Mareschal; J Sauvegrain
Journal:  Med Chir Dig       Date:  1975

2.  Clinical observations on the biliary system in cystic fibrosis.

Authors:  J N Isenberg; P R L'Heureux; W J Warwick; H L Sharp
Journal:  Am J Gastroenterol       Date:  1976-02       Impact factor: 10.864

3.  Malabsorption of bile acids in children with cystic fibrosis.

Authors:  A M Weber; C C Roy; C L Morin; R Lasalle
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

4.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.

Authors:  P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

5.  Differing sensitivities of gallbladder and pancreas to cholecystokinin-pancreozymin (CCK-PZ) in man.

Authors:  J R Malagelada; V L Go; W H Summerskill
Journal:  Gastroenterology       Date:  1973-05       Impact factor: 22.682

6.  Bile-rich duodenal fluid as an indicator of biliary lipid composition and its applicability to detection of lithogenic bile.

Authors:  Z R Vlahcevic; C C Bell; P Juttijudata; L Swell
Journal:  Am J Dig Dis       Date:  1971-09

7.  Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique.

Authors:  V L Go; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1970-03       Impact factor: 22.682

Review 8.  Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis.

Authors:  A M Weber; C C Roy; L Chartrand; G Lepage; O L Dufour; C L Morin; R Lasalle
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

9.  Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey.

Authors:  R H Dowling; E Mack; D M Small
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

10.  Bile composition at and after surgery in normal persons and patients with gallstones. Influence of cholecystectomy.

Authors:  E A Shaffer; J W Braasch; D M Small
Journal:  N Engl J Med       Date:  1972-12-28       Impact factor: 91.245

View more
  18 in total

1.  Liver and biliary problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 2.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 3.  Liver disease in cystic fibrosis.

Authors:  M S Tanner; C J Taylor
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

4.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.

Authors:  Dominique Debray; Dominique Rainteau; Véronique Barbu; Myriam Rouahi; Haquima El Mourabit; Stéphanie Lerondel; Colette Rey; Lydie Humbert; Dominique Wendum; Charles-Henry Cottart; Paul Dawson; Nicolas Chignard; Chantal Housset
Journal:  Gastroenterology       Date:  2012-02-24       Impact factor: 22.682

Review 5.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

6.  Ursodeoxycholic acid dissolution of gallstones in cystic fibrosis.

Authors:  B Salh; J Howat; K Webb
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

Review 7.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

8.  Bile acid secretion in cystic fibrosis.

Authors:  G P Davidson; T A Robb
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

Review 9.  Laboratory measurement of nutrition in cystic fibrosis.

Authors:  J Kelleher
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

10.  Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization.

Authors:  T V Strong; K Boehm; F S Collins
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.